PCM
AGIO icon

Prelude Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Prelude Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,085
Closed -$984K – 1221
2026
Q1 		$984K Sell
29,085
-4,600
-14% -$130K 0.08% 317
2025
Q4 		$917K Buy
+33,685
New +$1.18M 0.07% 336
2024
Q4 		– Sell
-21,000
Closed -$933K – 1191
2024
Q3 		$933K Buy
+21,000
New +$954K 0.06% 403
2024
Q2 		– Sell
-15,056
Closed -$440K – 1192
2024
Q1 		$440K Buy
+15,056
New +$403K 0.02% 688
2020
Q4 		– Sell
-1,281
Closed -$45K – 1235
2020
Q3 		$45K Sell
1,281
-2,804
-69% -$123K ﹤0.01% 1150
2020
Q2 		$218K Buy
+4,085
New +$189K 0.01% 715
2019
Q2 		– Sell
-140
Closed -$9K – 1617
2019
Q1 		$9K Buy
+140
New +$8.15K ﹤0.01% 1455
2018
Q4 		– Sell
-6,701
Closed -$517K – 1744
2018
Q3 		$517K Buy
6,701
+1,400
+26% +$113K 0.03% 519
2018
Q2 		$447K Buy
5,301
+5,152
+3,458% +$449K 0.03% 564
2018
Q1 		$12K Buy
+149
New +$11.5K ﹤0.01% 1322
2017
Q4 		– Sell
-4,215
Closed -$281K – 1329
2017
Q3 		$281K Buy
4,215
+739
+21% +$44.4K 0.03% 537
2017
Q2 		$179K Buy
+3,476
New +$178K 0.02% 610
2015
Q1 		– Sell
-3,013
Closed -$338K – 1909
2014
Q4 		$338K Buy
+3,013
New +$269K 0.05% 449

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Prelude Capital Management's AGIO Position: Q2 2026 in Review

Prelude Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 29,085 shares — an estimated $984K sold.

Prelude Capital Management first reported a position in AGIO in Q4 2014 and held it in 13 quarters. The position peaked at $984K in Q1 2026. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Prelude Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 29,085 Agios Pharmaceuticals shares in Q2 2026, an estimated $984K.
  • Prelude Capital Management first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 13 quarters.
  • Prelude Capital Management's Agios Pharmaceuticals position peaked at $984K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.